RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

1)The small company is not in a position to 'push the deal along', and if you think that is untrue, then that means that almost all of the literally hundreds of small biotech companies looking for a deal are somehow failing to do so. The larger companies hold the string, and you know what happens when you push a string.

2) My hypothetical model is a bit different: In this situation, everything is on the table (and I don't think we need a conference call to confirm this). So for example, if they are trying to negotiate an ADHD deal, the larger company's sense of leverage will vary depending on how close they think Cortex might be to signing a deal for something else, like SA. As soon as the latter happens, the ADHD company's leverage goes down, and conversely, a delay means that they can wait longer.

NeuroInvestment